{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:38:47Z","timestamp":1790419127385,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T00:00:00Z","timestamp":1404345600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0101325","type":"journal-article","created":{"date-parts":[[2014,7,3]],"date-time":"2014-07-03T17:52:51Z","timestamp":1404409971000},"page":"e101325","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":19,"title":["Combination Effects of Peramivir and Favipiravir against Oseltamivir-Resistant 2009 Pandemic Influenza A(H1N1) Infection in Mice"],"prefix":"10.1371","volume":"9","author":[{"given":"Sehee","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilseob","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangmoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Woong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Yong","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok-Il","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jin","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Won","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Joon","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luck Ju","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-Seong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4167\/jbv.2013.43.1.9","article-title":"Cell culture-based influenza vaccines as alternatives to egg-based vaccines","volume":"43","author":"I Lee","year":"2013","journal-title":"Journal of Bacteriology and Virology"},{"key":"ref2","unstructured":"Knipe DM, Howley PM (2006) Fields Virology, 5th edition; Wright PF, Neumann G, Kawaoka Y, editors: Lippincott Williams & Wilkins."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0092-8674(92)90219-3","article-title":"Unpacking the incoming influenza virus","volume":"69","author":"A Helenius","year":"1992","journal-title":"Cell"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nrd2400","article-title":"The war against influenza: discovery and development of sialidase inhibitors","volume":"6","author":"M von Itzstein","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1055\/s-0031-1283281","article-title":"Influenza drug resistance","volume":"32","author":"A Pizzorno","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2007.10.020","article-title":"Mutations of neuraminidase implicated in neuraminidase inhibitors resistance","volume":"41","author":"O Ferraris","year":"2008","journal-title":"J Clin Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"JD Bloom","year":"2010","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1086\/650464","article-title":"Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses","volume":"201","author":"M Baz","year":"2010","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1002431","DOI":"10.1371\/journal.ppat.1002431","article-title":"Role of permissive neuraminidase mutations in influenza A\/Brisbane\/59\/2007-like (H1N1) viruses","volume":"7","author":"Y Abed","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1128\/JVI.01424-10","article-title":"Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models","volume":"84","author":"CW Seibert","year":"2010","journal-title":"J Virol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1128\/JVI.00985-12","article-title":"Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation","volume":"86","author":"DD Wong","year":"2012","journal-title":"J Virol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1001079","DOI":"10.1371\/journal.ppat.1001079","article-title":"Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses","volume":"6","author":"M Kiso","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1017\/S0950268812001318","article-title":"Phylogenetic, molecular and drug-sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007\u20132011","volume":"141","author":"P Huang","year":"2013","journal-title":"Epidemiol Infect"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"7539","DOI":"10.1128\/JVI.00373-13","article-title":"Genetic requirement for hemagglutinin glycosylation and its implications for influenza A H1N1 virus evolution","volume":"87","author":"JI Kim","year":"2013","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e1000933","DOI":"10.1371\/journal.ppat.1000933","article-title":"Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A\/Turkey\/15\/06 (H5N1) influenza virus in ferrets","volume":"6","author":"NA Ilyushina","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1128\/JVI.00047-11","article-title":"Effect of an asparagine-to-serine mutation at position 294 in neuraminidase on the pathogenicity of highly pathogenic H5N1 influenza A virus","volume":"85","author":"M Kiso","year":"2011","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2013.08.090","article-title":"Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses","volume":"440","author":"S Park","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-405880-4.00006-8","article-title":"Influenza virus resistance to antiviral therapy","volume":"67","author":"E van der Vries","year":"2013","journal-title":"Adv Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12275-013-3384-2","article-title":"The anti-influenza virus effect of Phellinus igniarius extract","volume":"51","author":"S Lee","year":"2013","journal-title":"J Microbiol"},{"key":"ref20","first-page":"S17","article-title":"Combination therapy for patients with HIV-1 infection: the use of dual nucleoside analogues with protease inhibitors and other agents","volume":"12","author":"R Gulick","year":"1998","journal-title":"AIDS"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e9332","DOI":"10.1371\/journal.pone.0009332","article-title":"Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro","volume":"5","author":"JT Nguyen","year":"2010","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4167\/jbv.2012.42.4.284","article-title":"Antiviral agents against influenza viruses","volume":"42","author":"S Park","year":"2012","journal-title":"Journal of Bacteriology and Virology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/v2081510","article-title":"Combination chemotherapy for influenza","volume":"2","author":"EA Govorkova","year":"2010","journal-title":"Viruses"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1586\/eri.11.174","article-title":"Peramivir for the treatment of influenza","volume":"10","author":"AK Shetty","year":"2012","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2007.12.029","article-title":"Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A\/Vietnam\/1203\/04 (H5N1)","volume":"374","author":"NE Yun","year":"2008","journal-title":"Virology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1073\/pnas.0909603107","article-title":"T-705 (favipiravir) activity against lethal H5N1 influenza A viruses","volume":"107","author":"M Kiso","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e3725","DOI":"10.1371\/journal.pone.0003725","article-title":"Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin","volume":"3","author":"BB Gowen","year":"2008","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/jac\/dkp274","article-title":"Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells","volume":"64","author":"DF Smee","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.00933-09","article-title":"Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice","volume":"54","author":"DF Smee","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2012.03.001","article-title":"Combinations of favipiravir and peramivir for the treatment of pandemic influenza A\/California\/04\/2009 (H1N1) virus infections in mice","volume":"94","author":"EB Tarbet","year":"2012","journal-title":"Antiviral Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/s12275-013-3428-7","article-title":"DBA\/2 mouse as an animal model for anti-influenza drug efficacy evaluation","volume":"51","author":"JI Kim","year":"2013","journal-title":"J Microbiol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s12275-012-2541-3","article-title":"Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009\u20132011","volume":"50","author":"S Park","year":"2012","journal-title":"J Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0166-3542(90)90001-N","article-title":"A three-dimensional model to analyze drug-drug interactions","volume":"14","author":"MN Prichard","year":"1990","journal-title":"Antiviral Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1128\/AAC.00581-10","article-title":"Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays","volume":"54","author":"HT Nguyen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.antiviral.2009.07.003","article-title":"Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005\u20132008","volume":"83","author":"M Jonges","year":"2009","journal-title":"Antiviral Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1128\/JVI.00373-10","article-title":"Assessing the viral fitness of oseltamivir-resistant influenza viruses in ferrets, using a competitive-mixtures model","volume":"84","author":"AC Hurt","year":"2010","journal-title":"J Virol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/irv.12043","article-title":"Modeling the global transmission of antiviral-resistant influenza viruses","volume":"7","author":"DL Chao","year":"2013","journal-title":"Influenza Other Respi Viruses"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/AAC.45.3.743-748.2001","article-title":"Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities","volume":"45","author":"DF Smee","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/AAC.45.3.749-757.2001","article-title":"In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RJW-270201","volume":"45","author":"RW Sidwell","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/AAC.00132-11","article-title":"Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection","volume":"56","author":"N Sugaya","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.antiviral.2013.03.014","article-title":"Influenza virus resistance to neuraminidase inhibitors","volume":"98","author":"M Samson","year":"2013","journal-title":"Antiviral Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.39105.428981.BE","article-title":"Role of combination antiviral therapy in pandemic influenza and stockpiling implications","volume":"334","author":"S Tsiodras","year":"2007","journal-title":"BMJ"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000057668","article-title":"Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin","volume":"48","author":"DF Smee","year":"2002","journal-title":"Chemotherapy"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1128\/AAC.48.12.4855-4863.2004","article-title":"Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells","volume":"48","author":"EA Govorkova","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.antiviral.2010.09.020","article-title":"Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model","volume":"88","author":"S Bantia","year":"2010","journal-title":"Antiviral Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2010.07.003","article-title":"Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice","volume":"88","author":"DF Smee","year":"2010","journal-title":"Antiviral Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.antiviral.2012.07.002","article-title":"Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents","volume":"96","author":"DF Smee","year":"2012","journal-title":"Antiviral Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Y Furuta","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against influenza virus","volume":"49","author":"Y Furuta","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.1128\/JVI.05930-11","article-title":"The DBA.2 mouse is susceptible to disease following infection with a broad, but limited, range of influenza A and B viruses","volume":"85","author":"N Pica","year":"2011","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0101325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:32:24Z","timestamp":1540323144000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0101325"}},"subtitle":[],"editor":[{"given":"Balaji","family":"Manicassamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,3]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0101325","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,3]]}}}